Buy Three, Get the Fourth Free! | Start Saving >>
6291
SignalSilence® cdc25C siRNA (Human Specific)
siRNA

SignalSilence® cdc25C siRNA (Human Specific) #6291

This product is discontinued

Western Blotting

Western blot analysis of extracts from HeLa cells, transfected with control (-) or cdc25C (+) siRNA. cdc25C was detected using cdc25C antibody, and eIF4E was detected using eIF4E Antibody #9742. The cdc25C antibody confirms silencing of cdc25C expression, and the eIF4E Antibody is used to control for loading and specificity of cdc25C siRNA.

Learn more about how we get our images
Fluorescent Detection

Fluorescent detection of SignalSilence® Control siRNA (Fluorescein Conjugate) #6201 in living HeLa cells 24 hours post-transfection, demonstrating nearly 100% transfection efficiency.

Learn more about how we get our images

CST recommends transfection with 100 nM human-specific cdc25C siRNA 48 hours prior to cell lysis. See Protocol for transfection procedure.

Storage:

SignalSilence® siRNA is supplied in RNAse-free water. Aliquot and store at -20ºC.

SignalSilence® cdc25C siRNA from Cell Signaling Technology allows the researcher to specifically inhibit cdc25C expression using RNA interference, a method in which gene expression can be selectively silenced through the delivery of double stranded RNA molecules into the cell. All SignalSilence® siRNA products are rigorously tested in-house and have been shown to reduce protein expression in specified cell lines.

Cdc25 is a protein phosphatase responsible for dephosphorylating and activating cdc2, a crucial step in regulating the entry of all eukaryotic cells into mitosis (1). cdc25C is constitutively phosphorylated at Ser216 throughout interphase by c-TAK1, while phosphorylation at this site is DNA damage-dependent at the G2/M checkpoint (2). When phosphorylated at Ser216, cdc25C binds to members of the 14-3-3 family of proteins, sequestering cdc25C in the cytoplasm and thereby preventing premature mitosis (3). The checkpoint kinases Chk1 and Chk2 phosphorylate cdc25C at Ser216 in response to DNA damage (4,5).

Small interfering RNA (siRNA) has been used to specifically silence cdc25C expression in HeLa cells, causing a G1/S checkpoint arrest (6).

  1. Jessus, C. and Ozon, R. (1995) Prog. Cell Cycle Res. 1, 215-228.
  2. Peng, C.Y. et al. (1997) Science 277, 1501-1505.
  3. Kumagai, A. and Dunphy, W.G. (1999) Genes Dev. 13, 1067-1072.
  4. Blasina, A. et al. (1999) Curr Biol 9, 1-10.
  5. Furnari, B. et al. (1999) Mol Biol Cell 10, 833-45.
  6. Turowski, P. et al. (2003) Mol. Biol. Cell 14, 2984-2998.
Entrez-Gene Id
995
Swiss-Prot Acc.
P30307
For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
SignalSilence is a registered trademark of Cell Signaling Technology, Inc.
Limited Use Label License, RNA interference: This product is licensed under European Patent 1144623 and foreign equivalents from Ribopharma AG, Kulmbach, Germany and is provided only for use in non-commercial research specifically excluding use (a) in drug discovery or drug development, including target identification or target validation, by or on behalf of a commercial entity, (b) for contract research or commercial screening services, (c) for the production or manufacture of siRNA-related products for sale, or (d) for the generation of commercial databases for sale to Third Parties. Information about licenses for these and other commercial uses is available from Ribopharma AG, Fritz-Hornschuch-Str. 9, D-95326 Kulmbach, Germany.

Upstream / Downstream

pathwayImage

Explore pathways related to this product.